Mahatma Gandhi Institute of Medical Sciences Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2006
NCT00704899
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Mahatma Gandhi Institute of Medical Sciences | MGM School Of Physiotherapy,Aurangabad,Maharashtra, India

Active Ingredients

Drugs in Phase 3 Trials (1)

amitriptyline (elavil) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fibromyalgia (Phase 3)

Myofascial Pain Syndromes (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1